0001225208-16-043118.txt : 20161213 0001225208-16-043118.hdr.sgml : 20161213 20161213185106 ACCESSION NUMBER: 0001225208-16-043118 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20161209 FILED AS OF DATE: 20161213 DATE AS OF CHANGE: 20161213 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BARD C R INC /NJ/ CENTRAL INDEX KEY: 0000009892 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 221454160 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 730 CENTRAL AVE CITY: MURRAY HILL STATE: NJ ZIP: 07974 BUSINESS PHONE: 9082778000 MAIL ADDRESS: STREET 1: 730 CENTRAL AVENUE CITY: MURRAY HILL STATE: NJ ZIP: 07974 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DeFord John A CENTRAL INDEX KEY: 0001403373 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-06926 FILM NUMBER: 162050029 MAIL ADDRESS: STREET 1: C R BARD INC STREET 2: 730 CENTRAL AVENUE CITY: MURRAY HILL STATE: NJ ZIP: 07974 4 1 doc4.xml X0306 4 2016-12-09 0000009892 BARD C R INC /NJ/ BCR 0001403373 DeFord John A C/O C. R. BARD, INC. 730 CENTRAL AVENUE MURRAY HILL NJ 07974 1 Sr. VP Sci Tech and Clin Afrs Common Stock 2016-12-09 4 M 0 3292.0000 186.4250 A 24899.0816 D Common Stock 2016-12-09 4 S 0 3292.0000 215.0000 D 21607.0816 D Common Stock 2016-12-12 4 M 0 4663.0000 97.6850 A 26270.0816 D Common Stock 2016-12-12 4 M 0 4161.0000 136.3700 A 30431.0816 D Common Stock 2016-12-12 4 M 0 3767.0000 168.8650 A 34198.0816 D Common Stock 2016-12-12 4 S 0 826.0000 218.8347 D 33372.0816 D Common Stock 2016-12-12 4 S 0 1977.0000 220.3770 D 31395.0816 D Common Stock 2016-12-12 4 S 0 4167.0000 216.9804 D 27228.0816 D Common Stock 2016-12-12 4 S 0 5621.0000 219.6286 D 21607.0816 D Common Stock 71.3320 I 401(k) Plan Option (Right to Buy) 186.4250 2016-12-09 4 M 0 3292.0000 0.0000 D 2025-12-09 Common Stock 3292.0000 9879.0000 D Option (Right to Buy) 168.8650 2016-12-12 4 M 0 3767.0000 0.0000 D 2024-12-10 Common Stock 3767.0000 7535.0000 D Option (Right to Buy) 136.3700 2016-12-12 4 M 0 4161.0000 0.0000 D 2023-12-11 Common Stock 4161.0000 4161.0000 D Option (Right to Buy) 97.6850 2016-12-12 4 M 0 4663.0000 0.0000 D 2022-12-12 Common Stock 4663.0000 0.0000 D Option exercise and sales are pursuant to a previously disclosed 10b5-1 plan. Includes 0.0632 shares acquired under the Company's Dividend Reinvestment Plan from July 30, 2016 to November 4, 2016. Includes 0.001 shares acquired under the Company's Employee Stock Purchase Plan from August 2, 2016 to November 7, 2016. Represents the weighted average sales price for price increments ranging from $218.17 to $219.10. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4. Represents the weighted average sales price for price increments ranging from $220.18 to $220.78. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4. Represents the weighted average sales price for price increments ranging from $216.62 to $217.23. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4. Represents the weighted average sales price for price increments ranging from $219.18 to $220.17. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4. Includes 0.101 shares acquired under the Company's 401(k) Plan from July 30, 2016 to November 4, 2016. Options granted under 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated). Of this option grant 3,292 options vested on December 9, 2016 and the remaining options vest in three annual installments beginning on December 9, 2017. Of this option grant 3,767 options vested on December 10, 2016 and the remaining options vest in two annual installments beginning on December 10, 2017. Of this option grant 4,161 options vested on December 11, 2016 and the remaining options vest on December 11, 2017. Options fully vested and are currently exercisable. Myra McGinley, Attorney-in-Fact 2016-12-13